The Amsterdam Declaration on Graves' orbitopathy.

نویسندگان

  • Petros Perros
  • Wilmar M Wiersinga
چکیده

This statement holds true now as it did nearly 20 years ago (1). Some patients have an excellent outcome, while others may suffer a long and debilitating illness. Those who do well are not the recipients of new breakthroughs in treatment. The variance in outcome is to some extent a reflection of inequalities in availability of expertise and delivery of medical and surgical treatments that have changed little for decades (2,3).

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers.

Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers The European Group on Graves’ Orbitopathy (EUGOGO): W M Wiersinga, P Perros, G J Kahaly, M P Mourits, L Baldeschi, K Boboridis, A Boschi, A J Dickinson, P Kendall-Taylor, G E Krassas, C M Lane, J H Lazarus, C Marcocci, M Marino,...

متن کامل

Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures European Group on Graves’ Orbitopathy (EUGOGO),

Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: http://uba.uva.nl/en/contact, or a letter to: Library of ...

متن کامل

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease

Graves' disease, an autoimmune disease with heterogeneous symptoms including Graves' orbitopathy, has a combined genetic/environmental background, where variations within CD28/CTLA-4/ICOS genes are considered as disease markers.Association of CD28c.17+3T>C(rs3116496), CTLA-4g.319C>T(rs5742909), CTLA-4c.49A>G(rs231775), CTLA-4g.*642AT(8_33), CT60(rs3087243), Jo31(rs11571302), ICOSc.1554+4GT(8_15...

متن کامل

Optimal management of Graves orbitopathy: a multidisciplinary approach.

Graves' thyroid disease is a relatively common disorder in endocrinology and general internal medicine practice. Graves' hyperthyroidism is mediated by circulating stimulating autoantibodies. Up to 60% of patients with Graves' hyperthyroidism develop some form of Graves' orbitopathy. Immune reactivity to the thyroid-stimulating hormone receptor is also thought to play a role in the immunopathog...

متن کامل

Statins and Thyroidectomy May Reduce the 
Risk of Orbitopathy Developing in Patients with 
Graves’ Disease

Background Graves’ orbitopathy (GO) is a component of Graves’ disease (GD) that is difficult to treat and may be very debilitating for the patient. Orbitopathy (ophthalmopathy [harder to pronounce]) is a significant problem for about 5% to 10% of patients with Graves’ disease. The factors that cause a predisposition to it are not clear. The current study examines a database of patients with Gra...

متن کامل

ذخیره در منابع من

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Thyroid : official journal of the American Thyroid Association

دوره 20 3  شماره 

صفحات  -

تاریخ انتشار 2010